Copolymer 1 from the laboratory to FDA.

Adjuvants, Immunologic/chemistry,therapeutic use Animals Autoimmune Diseases/drug therapy,immunology Clinical Trials as Topic Cross Reactions Disease Models, Animal Drug Design Encephalomyelitis, Autoimmune, Experimental/drug therapy,immunology Glatiramer Acetate Histocompatibility Antigens Class II/immunology Humans Immunosuppressive Agents/chemistry,immunology,therapeutic use Israel Laboratories Multiple Sclerosis/drug therapy,immunology Peptides/chemistry,immunology,therapeutic use Polymers/chemistry,therapeutic use T-Lymphocytes/drug effects,immunology T-Lymphocytes, Regulatory/drug effects,immunology United States United States Food and Drug Administration

Adjuvants, Immunologic Histocompatibility Antigens Class II Immunosuppressive Agents Peptides Polymers Glatiramer Acetate